Prescribing patterns of budesonide/formoterol maintenance and reliever therapy in patients with asthma in Sweden-Reference-Cited by-同舟云学术

Prescribing patterns of budesonide/formoterol maintenance and reliever therapy in patients with asthma in Sweden

Published:2023-04-11 Issue:8 Volume:78 Page:2311-2314
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Janson Christer¹^ORCID,Melén Erik²^ORCID,de Fine Licht Sofie³^ORCID,Telg Gunilla³^ORCID,Maslova Ekaterina⁴^ORCID,Tran Trung N.⁵^ORCID,Surmont Filip⁴^ORCID,Wiklund Fredrik⁶^ORCID,Olsson Urban⁶^ORCID,Nwaru Bright I.⁷⁸^ORCID,Ekström Magnus⁹^ORCID

Affiliation:

1. Department of Medical Sciences, Respiratory, Allergy and Sleep Research Uppsala University Uppsala Sweden

2. Department of Clinical Science and Education, Karolinska Institutet Södersjukhuset Stockholm Sweden

3. AstraZeneca Nordic Södertälje Sweden

4. AstraZeneca Cambridge UK

5. AstraZeneca Gaithersburg Maryland USA

6. Statisticon AB Uppsala Sweden

7. Krefting Research Centre, Institute of Medicine University of Gothenburg Gothenburg Sweden

8. Wallenberg Centre for Molecular and Translational Medicine University of Gothenburg Gothenburg Sweden

9. Department of Respiratory Medicine and Allergology Lund University Lund Sweden

Funder

AstraZeneca

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/all.15710

Reference15 articles.

1. Global Initiative for Asthma (GINA).Global Strategy for Asthma Management and Prevention.2022.Accessed 07 June 2022.https://ginasthma.org/wp‐content/uploads/2022/05/GINA‐Main‐Report‐2022‐FINAL‐22‐05‐03‐WMS.pdf

2. Budesonide/Formoterol in a Single Inhaler for Maintenance and Relief in Mild-to-Moderate Asthma

3. Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations

4. Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option?

5. BellJ MaslovaE MillerP et al.Carbon footprint of maintenance and reliever therapy (MART) versus maintenance plus SABA (Mx+SABA) regimens for asthma: results from the healthCARe‐Based envirONmental cost of treatment (CARBON) programme [abstract]. European Respiratory Society (ERS) International Congress 2022; September 4–6 2022;Barcelona Spain.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A snapshot of SABA co‐prescribing with ICS‐formoterol maintenance and reliever therapy;Respirology;2024-08-11

2. Combined therapy of broncho-obstructive pathology: two solutions to one problem;Meditsinskiy sovet = Medical Council;2023-11-15